NCT01351116 A Trial to Evaluate the Improvement in Lung Cancer Patients Receiving Radiation With or Without Brachytherapy Status COMPLETED Phase PHASE3
NCT01342965 A Study of Erlotinib (Tarceva) Versus Gemcitabine/Cisplatin as First-line Treatment in Patients With Non-small Cell Lung Cancer With EGFR Mutations Status COMPLETED Phase PHASE3
NCT01327612 Open Label Extension Study of Conatumumab and Ganitumab (AMG 479) Status COMPLETED Phase PHASE2
NCT01297491 Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT01297101 Evaluating Efficacy and Safety of Erlotinib Versus Gemcitabine Plus Cisplatin as Neoadjuvant Chemotherapy Status TEMPORARILY_NOT_AVAILABLE Phase N/A
NCT01291017 Cyclin Dependent Kinase (CDK)4/6 Inhibitor, PD0332991 in Advanced Non-small Cell Lung Cancer NSCLC. Status COMPLETED Phase PHASE2
NCT01287962 Apatinib in the Treatment of Advanced Non-squamous Non-small Cell Lung Cancer Status UNKNOWN Phase PHASE3
NCT01287754 A Study of Tarceva (Erlotinib) in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer Who Present EGFR Mutations Status COMPLETED Phase PHASE4
NCT01282450 Concurrent and Non-concurrent Chemo-radiotherapy or Radiotherapy Alone for Patients With Oligo-metastatic Stage IV Non-small Cell Lung Cancer (NSCLC) Status COMPLETED Phase PHASE2
NCT01279798 Expanded Access Multicenter Study of Lucanix® (Belagenpumatucel-L) Status NO_LONGER_AVAILABLE Phase N/A
NCT01268059 A Study of Carboplatin and Paclitaxel With or Without MEDI-575 in Untreated, Advanced Non-Small Cell Lung Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT01263886 Trial of Ombrabulin (AVE8062) in Combination With Taxane and Platinum in Patients With Non-small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT01259089 Hsp90 Inhibitor AUY922 and Erlotinib Hydrochloride in Treating Patients With Stage IIIB-IV Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT01258127 Pemetrexed/Carboplatin vs Vinorelbine/Carboplatin in Patients With Completely Resected Non-small Cell Lung Cancer (NSCLC) Status UNKNOWN Phase N/A
NCT01243775 BELotaxel(Docetaxel) and bellOXa(Oxaliplatin) in Advanced NSCLC Status COMPLETED Phase PHASE2
NCT01234038 Safety and Tolerability Study of ISIS EIF4E Rx in Combination With Carboplatin and Paclitaxel Status COMPLETED Phase PHASE1/PHASE2
NCT01230710 A Study of Tarceva (Erlotinib) in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer Following 4 Cycles of Platinum-based Chemotherapy Without Disease Progression Status COMPLETED Phase PHASE4
NCT01225302 A Study of Linifanib (ABT-869) in Combination With Carboplatin/Paclitaxel in Japanese Subjects With Non-Small Cell Lung Cancer (NSCLC) Status COMPLETED Phase PHASE1